BRKR
Bruker Corporation
Medical Devices · Healthcare · United States
62.00
close · 2026-10-29
value
56
cheaper than peers56
quality
49
stronger fundamentals49
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 2 years ago | 5.0% | 95 |
| cash flow yield, 2 years ago | 2.8% | 86 |
| cash flow yield, 3 years ago | 1.7% | 77 |
| earnings yield, 3 years ago | 3.4% | 68 |
| price to sales | 2.31× | 60 |
| earnings yield, 1 year ago | 1.3% | 59 |
| price to book | 3.97× | 42 |
| forward P/E | 25.80× | 42 |
| earnings yield, latest year | -0.3% | 41 |
| cash flow yield, 1 year ago | 1.5% | 41 |
| cash flow yield, latest year | 0.2% | 32 |
| EV to EBITDA | 23.36× | 20 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 6.2% | 70 |
| return on equity | -0.4% | 65 |
| debt to equity | 68.1% | 39 |
| revenue growth | 2.7% | 32 |
4 of 4 measures available
Facts
| market cap | $9B |
| free cash flow | $212.5M |
| employees | 11,085 |
| first trade | 2000-08-04 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.15 | 0.76 | 2.90 | 1.99 |
| free cash flow | $13.9M | $136.0M | $243.2M | $145.2M |
| net income | -$8.6M | $113.1M | $427.2M | $296.6M |
| revenue | $3.44B | $3.37B | $2.96B | $2.53B |
| unusual items | -$154.2M | -$124.0M | $71.3M | -$29.3M |